Top 50 Biotechnology Startup Investors in United Kingdom (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SOSV
VC Fund
|
85 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $50k–$5M |
|
UK Innovation & Science Seed Fund
VC Fund
|
70 | United Kingdom, United States | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $582k–$6.7M |
|
Parkwalk Advisors
VC Fund
|
66 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $991k–$44M |
|
Scottish Enterprise
VC Fund
|
63 | United Kingdom, United States, Switzerland | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $119k–$8.4M |
|
Future Planet Capital
VC Fund
|
53 | United Kingdom, United States, Singapore | Seed, Convertible Note | Biotechnology, Health Care, Software | $670k–$5.1M |
|
Oxford Science Enterprises
VC Fund
|
53 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $1.3M–$168M |
|
SFC Capital
VC Fund
|
52 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $123k–$2.5M |
|
Scottish Investment Bank
VC Fund
|
40 | United Kingdom, United States, France | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Health Care | $199k–$7.5M |
|
Oxford Technology Management
VC Fund
|
37 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $33k–$8.5M |
|
Jonathan Milner
Angel
|
33 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
IP Group
VC Fund
|
31 | United Kingdom, United States, Australia | Seed, Series A, Series B | Biotechnology, Health Care, Information Technology | $265k–$68M |
|
O2h Ventures
VC Fund
|
30 | United Kingdom, Hungary | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Pharmaceutical | $603k–$25M |
|
Mercia Fund Managers
VC Fund
|
28 | United Kingdom, United States, Hungary | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $250k–$14M |
|
Business Growth Fund
VC Fund
|
28 | United Kingdom, Ireland, United States | Venture - Series Unknown, Private Equity, Series A | Software, Manufacturing, Information Technology | $3.4M–$22M |
|
Development Bank of Wales
VC Fund
|
27 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.5M |
|
Catapult Ventures
VC Fund
|
27 | United Kingdom, United States, Israel | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $150k–$5.6M |
|
Northstar Ventures
VC Fund
|
26 | United Kingdom, United States, Indonesia | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $46k–$10M |
|
Epidarex Capital
VC Fund
|
25 | United Kingdom, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $551k–$48M |
|
Syncona Partners LLP
VC Fund
|
25 | United Kingdom, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.9M–$156M |
|
Kelvin Capital
VC Fund
|
24 | United Kingdom, United States | Seed, Venture - Series Unknown | Health Care, Biotechnology, Manufacturing | $167k–$4.5M |
|
Archangels
VC Fund
|
24 | United Kingdom, United States | Venture - Series Unknown, Seed | Software, Health Care, Biotechnology | $867k–$6.6M |
|
Octopus Ventures
VC Fund
|
23 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.1M–$43M |
|
Sofinnova Partners
VC Fund
|
23 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Deepbridge Capital
VC Fund
|
22 | United Kingdom, Spain, Australia | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $142k–$15M |
|
Eos
VC Fund
|
21 | United Kingdom, Ireland | Seed, Series A | Biotechnology, Health Care, Medical | $1.5M–$47M |
|
SOSV SF & NY (Fka IndieBio)
VC Fund
|
21 | United States, United Kingdom, Canada | Seed, Pre-Seed, Convertible Note | Biotechnology, Health Care, Medical | $50k–$5M |
|
Newable Private Investing
VC Fund
|
21 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.6M |
|
AlbionVC
VC Fund
|
21 | United Kingdom, United States, France | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.4M–$45M |
|
Par Equity
VC Fund
|
21 | United Kingdom, United States, Brazil | Venture - Series Unknown, Seed | Software, Manufacturing, Information Technology | $103k–$4.3M |
|
Innovate UK
VC Fund
|
21 | United Kingdom, United States, Ireland | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Software | $58k–$3.5M |
|
GM&C Life Sciences Fund
VC Fund
|
20 | United Kingdom, Italy, Germany | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $94k–$5.8M |
|
Cambridge Innovation Capital
VC Fund
|
20 | United Kingdom, United States, Ireland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2M–$73M |
|
Cambridge Angels group
VC Fund
|
20 | United Kingdom, United States, Estonia | Seed, Series A, Venture - Series Unknown | Software, Health Care, Biotechnology | $375k–$12M |
|
IQ Capital
VC Fund
|
19 | United Kingdom, United States, Germany | Seed, Series A, Venture - Series Unknown | Software, Artificial Intelligence, Machine Learning | $1.3M–$40M |
|
Wren Capital
VC Fund
|
19 | United Kingdom | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Medical | $1.1M–$33M |
|
Mercia Asset Management
VC Fund
|
18 | United Kingdom, United States | Venture - Series Unknown, Series A, Seed | Software, Information Technology, Health Care | $576k–$13M |
|
Calculus Capital
VC Fund
|
18 | United Kingdom, United States, Ireland | Venture - Series Unknown, Series A | Biotechnology, Software, Medical | $1.9M–$10M |
|
Oxford Capital
VC Fund
|
18 | United Kingdom, United States, France | Seed, Series A | Software, Health Care, Biotechnology | $1.7M–$16M |
|
Hoxton Ventures
VC Fund
|
18 | United Kingdom, United States, Canada | Seed, Series A, Series B | Artificial Intelligence, Software, Health Care | $1.9M–$35M |
|
Longwall Venture
VC Fund
|
17 | United Kingdom, Germany, Philippines | Venture - Series Unknown, Seed, Series A | Biotechnology, Health Care, Medical Device | $818k–$27M |
|
Entrepreneurs First
VC Fund
|
16 | United Kingdom, Singapore, United States | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Machine Learning | $54k–$41M |
|
Maven Capital Partners
VC Fund
|
16 | United Kingdom, United States, Germany | Venture - Series Unknown, Seed, Private Equity | Software, Information Technology, Manufacturing | $648k–$8.3M |
|
TRICAPITAL
VC Fund
|
16 | United Kingdom, France | Seed, Series B | Biotechnology, Software, Health Care | |
|
Seedcamp
VC Fund
|
15 | United Kingdom, United States, France | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $587k–$30M |
|
Amadeus Capital Partners
VC Fund
|
15 | United Kingdom, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $800k–$60M |
|
Meltwind Advisory
VC Fund
|
15 | United Kingdom, United States | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Therapeutics | $996k–$94M |
|
Techstart Ventures
VC Fund
|
14 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $197k–$5.7M |
|
24 Haymarket
VC Fund
|
14 | United Kingdom, United States | Venture - Series Unknown, Seed, Series A | Health Care, Software, Biotechnology | $107k–$16M |
|
Selvedge Venture
VC Fund
|
14 | United Kingdom, United States, Canada | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $1.1M–$30M |
|
Forbion Capital Partners
VC Fund
|
14 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $16M–$180M |
| Access all 2246 investors in United Kingdom Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3729
- Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 151
- Round size: Seed $582k–$5.9M; Venture - Series Unknown $1M–$6.7M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- StandardX — StandardX is a deep-tech company building the isotope refinery powered by a scalable, compact particle accelerator platform.
- SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 338
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $1.8M–$44M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
- Quantum Motion — Quantum Motion delivers scalable silicon-based quantum computing using standard semiconductor manufacturing technology.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 403
- Round size: Seed $387k–$4.3M; Grant $119k–$4.8M; Venture - Series Unknown $681k–$8.4M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
- GLORIAH — Nurse founded, natural intimate hydration oils and gels for menopause.
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 289
- Round size: Seed $670k–$5.1M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 210
- Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $299M in 2022
Portfolio highlights
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
- OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 783
- Round size: Seed $123k–$2M; Pre-Seed $170k–$858k; Venture - Series Unknown $201k–$2.5M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Obsero — Obsero is an AI search intelligence platform and consultancy designed for marketing and communications teams. The platform tracks, measures, and optimizes how brands surface, get cited, and are recommended across Large Language Models (LLMs) and AI search assistants.
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
- NEARHUMAN — Nearhuman develops intelligent safety systems for micromobility and other physical-world devices. The company focuses on edge AI and computer vision that run directly on vehicles such as e-scooters and e-bikes to detect hazards, monitor pedestrian proximity, and support real-time decision making. Its flagship product, Scootrr, is an AI-powered safety platform that enables on-device perception, automatic deceleration, and safety analytics without reliance on cloud connectivity. Nearhuman designs its technology to integrate with existing shared micromobility fleets, collaborating with operators, vehicle manufacturers, and research partners. The company also provides dashboards and tools that turn on-vehicle events into route-level safety intelligence for stakeholders such as fleet operators and city authorities. Its work spans hardware vision kits, embedded firmware, perception models, and supporting software for deployment and monitoring.
Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 291
- Round size: Seed $331k–$3.1M; Series A $1.7M–$7.5M; Venture - Series Unknown $199k–$4.1M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- RoslinCT — We are the prefered global partner for cell and gene therapy solutions. With our wealth of expertise and infrastructure, we can support you at every step of your advanced therapy journey.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 112
- Round size: Seed $33k–$2.2M; Series A $786k–$8.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- HydRegen — HydRegen is a biotechnology company that provides sustainable solutions for chemical manufacturing. HydRegen was founded in 2020 and was headquartered in Oxford, United Kingdom.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 234
- Round size: Seed $265k–$7.6M; Series A $2.4M–$30M; Series B $7.9M–$68M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely actively investing — fresh fund, raised $50M in 2026
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Matter Machine — Matter Machine is an AI-driven materials discovery company that creates technologies that use materials chemistry, machine learning, and automated experimentation to speed up the discovery and optimization of next-generation materials.
- Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 60
- Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Healx — Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AItechnology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 148
- Round size: Seed $250k–$2.1M; Series A $1.3M–$14M; Venture - Series Unknown $394k–$5.3M
- Lead/follow: 68% lead, 32% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Private Equity, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 608
- Round size: Series A $4.1M–$21M; Private Equity $6.4M–$22M; Venture - Series Unknown $3.4M–$16M
- Lead/follow: 86% lead, 14% follow
- Last fund: Likely still investing — raised $97M in 2022
Portfolio highlights
- Camino — Camino Leisure Holdings is a Spanish bar and restaurant that serves authentic food and wines.
- Arran Aromatics —
- Boost Juice Bars UK — Boost Juice Bars UK offer a range of smoothies and freshly squeezed juice products.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 296
- Round size: Seed $279k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.5M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
- Outlook Expeditions — Outlook Expeditions provide overseas educational expeditions, adventure travel and service-learning projects for schools.
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK. Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of pounds in revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 279
- Round size: Seed $46k–$1.4M; Series A $295k–$10M; Venture - Series Unknown $261k–$3.8M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $20M in 2024
Portfolio highlights
- OneClickComply — OneClickComply automates ISO 27001, SOC 2, Cyber Essentials and 240+ standards: evidence from 13,000+ tools, one-click fixes and an in-house audit team.
- Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
- Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 53
- Round size: Seed $551k–$8.5M; Series A $2.6M–$40M; Series B $2.4M–$48M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely actively investing — fresh fund, raised $145M in 2026
Portfolio highlights
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 78
- Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right companywith the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 111
- Round size: Seed $167k–$1.9M; Venture - Series Unknown $485k–$4.5M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
- Aurora Avionics — Accelerating launch-vehicle development with flexible and modular avionics platforms.
- Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 88
- Round size: Seed $1.3M–$6.6M; Venture - Series Unknown $867k–$6.3M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
- Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
- iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 442
- Round size: Seed $2.1M–$12M; Series A $3.4M–$22M; Series B $8M–$43M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $108M in 2019
Portfolio highlights
- Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
- Living Optics — Living Optics is commercializing next generation imaging technology which leverages a compact camera system based on breakthroughs in hardware design and software processing.
- Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 353
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Ireland
Investor stats
- Total investments: 45
- Round size: Seed $1.5M–$11M; Series A $1.6M–$47M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- TaiSan — A polymer-electrolyte sodium battery for the e-bike and scooter fleet.
- Nami Surgical — Despite advances in robotic surgery, integrated ultrasonic energy remains unavailable in wristed robotic surgical systems
- Scarlet Therapeutics — Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 676
- Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
- Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
- Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Newable exists to power business growth. Our strategy of Buy, Grow, Realise focuses on the regulated B2B market.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 106
- Round size: Seed $196k–$3.1M; Series A $1.5M–$5.6M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
AlbionVC backs Europe’s visionary founders solving the world’s hardest problems. We bring capital, know-how, and a shared ambition to win. With £1 billion in venture funds and convictionled investing across frontier technologies, our track record spans 100+ exits and early support for global champions such as Booking.com, Quantexa, Oviva, Elliptic and tem. From the first concept to global scale, we back founders bold enough to own the future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 180
- Round size: Seed $2.4M–$12M; Series A $3.9M–$19M; Series B $10M–$45M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Oshen — Oshen is a technology enterprise that creates miniature autonomous sailboats designed for persistent, wide-area ocean tracking.
- Outerlimit — Outerlimit is an AI security company focused on securing and governing agentic AI systems. Its platform provides visibility into AI agent activity, identity and access controls, risk assessment, and runtime security. The company helps organizations establish security and governance controls for AI agents operating across enterprise environments and manage their access to applications, data, and systems.
- Gravitee — Open Source API Management Platform - Gravitee
Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States, Brazil
Investor stats
- Total investments: 305
- Round size: Seed $253k–$4.3M; Venture - Series Unknown $103k–$3.3M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely still investing — raised $122M in 2023
Portfolio highlights
- Fuuse — Fuuse is an electric vehicle charge point management system that enables your chargers to deliver more for you and your drivers.
- PathXL — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- Skylark Lasers — UniKLasers specialises in single frequency, continuous wave DPSS lasers at mid- to high power. Suitable for Raman, Holography, Interferometry, Microscopy, Metrology, Quantum Technologies, and more
Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 1251
- Round size: Seed $143k–$3.5M; Grant $62k–$1.8M; Pre-Seed $58k–$1.3M
- Lead/follow: 76% lead, 24% follow
Portfolio highlights
- Neela Biotech — Transforming organic waste into carbon-negative sustainable aviation fuels through innovative biotechnology and AI.
- Stride Health Group — Digital health optimisation company, helping how people understand and optimise their health, fitness and longevity.
- Alchera Technologies — Alchera's AI-powered, cloud-based software platform provides real-time data on the movement of vehicles and pedestrians around cities and major infrastructure
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 36
- Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M; Venture - Series Unknown $4.3M–$5.8M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Infex Therapeutics — Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 119
- Round size: Seed $2M–$31M; Series A $2.6M–$73M; Series B $8.2M–$68M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $332M in 2025
Portfolio highlights
- Trent AI — The agentic AI security platform that works like an AI security engineer, finding the real risk in your code, cloud, and AI agents and verifying every fix.
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
- TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK. Typical funding requirements that the Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds. Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 143
- Round size: Seed $446k–$3M; Series A $2M–$9.5M; Venture - Series Unknown $375k–$12M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Orthofuse — Orthofuse designs and manufacturers advance orthopaedic solutions using 3D printing technology. Their focus is on bringing precision and simplicity to complex surgical procedures, creating implants and systems that fit naturally into a surgeon's workflow while delivering dependable outcomes.
- Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
IQ Capital is a dedicated European deep tech venture capital firm, built on the conviction that frontier technology will underpin the next generation of globally significant companies. We back founders leveraging scientific breakthroughs to build enduring global businesses. We have invested in over 100 of Europe's most ambitious deep tech teams across six funds since 2005.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 215
- Round size: Seed $1.3M–$13M; Series A $4.7M–$40M; Venture - Series Unknown $1.4M–$30M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
- Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
- Undecimal Bio — Undecimal Bio operates as a platform biotechnology company that develops targeted delivery mechanisms for small interfering RNA (siRNA) therapeutics. The company utilizes a proprietary platform that combines combinatorial chemistry libraries with transformer-based artificial intelligence to discover molecular conjugates capable of guiding genetic medicines to specified cells outside of the liver. This approach aims to circumvent traditional delivery constraints to expand the reach of RNA therapeutics into a broader range of therapeutic areas and human organs.
Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devices to satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done. Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 35
- Round size: Seed $1.9M–$5M; Series A $2.5M–$33M; Venture - Series Unknown $1.1M–$8.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SenseAI — SenseAIsoftware dramatically speeds up image acquisition while reducing sample damage from high-energy electron beams, offering up to 100x improvements in efficiency without loss of image integrity.
- SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
- Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 112
- Round size: Seed $576k–$3.2M; Series A $2.2M–$13M; Venture - Series Unknown $659k–$12M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $38M in 2018
Portfolio highlights
- StratoBayes — Automated stratigraphic correlation with quantified uncertainty, built on Bayesian statistical inference.
- Camena Bioscience — Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
- Warwick Acoustics Ltd — Warwick Acoustics is a UK-based technology company specialising in the development of HighRes Audio solutions for the automotive and headphone markets based on its patented High Precision Electrostatic Laminate technology (HPELs). Their ultra thin, lightweight HPELs deliver audiophile performance across a bandwidth several octaves greater thantraditional moving coil speakers in a form factor that is less than one quarter the weight, and one tenth of the thickness. In addition, HPELs offer designers unparalleled flexibility to shaped and form a speaker to individual design requirements.
At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile. They look to make £2-5 million investments in established companies with proven management teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 81
- Round size: Series A $2.5M–$10M; Venture - Series Unknown $1.9M–$8.3M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Edify Systems — The Human-First AI platform for multi-site food and beverage operators. Tighter margins, less waste, more time on the floor.
- Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
- Resurrect Bio — Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide traits for breeders.
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 164
- Round size: Seed $1.7M–$3.9M; Series A $3.2M–$16M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $66M in 2015
Portfolio highlights
- Flyttr — Flyttr is the leader in developing and deploying biosecurity countermeasures against critical pest threats that spread disease, threaten food security.
- Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
- Noggin HQ — The next generation of credit referencing is coming. Look busy.
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 141
- Round size: Seed $1.9M–$12M; Series A $5M–$28M; Series B $6M–$35M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $60M in 2026
Portfolio highlights
- Preply — Looking for a tutor? Preply is the best platform for private online lessons with a flexible payment system and affordable prices. Book your first lesson.
- Veridion — Veridion is a living digital replica of the business world. Decision-grade data for enterprise scale systems
- Fabrica AI — Fabrica AI offers a revolutionary platform for faster robot development, using custom hardware designs and learned optimal control to increase efficiency while minimizing complexity and cost. With a vision for a future where robot development takes days, not years.
Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, Germany, Philippines
Investor stats
- Total investments: 51
- Round size: Seed $818k–$5.4M; Series A $2.8M–$16M; Venture - Series Unknown $1.7M–$27M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $98M in 2017
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- Kinomica — Kinomica is a proteomic-data science and diagnostics company specializing in cell signalling. Kinomica offers KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage.
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Singapore, United States
Investor stats
- Total investments: 485
- Round size: Seed $54k–$6.7M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- ByteAsk — Derisk your AI agents
- Sourcepulse — Your early warning system for software delivery (YC S23)
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Private Equity
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 231
- Round size: Seed $783k–$5M; Private Equity $981k–$6.4M; Venture - Series Unknown $648k–$8.3M
- Lead/follow: 74% lead, 26% follow
- Last fund: May invest from a new fund soon — raised $132M in 2019
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series B
- Geography: United Kingdom, France
Investor stats
- Total investments: 49
- Lead/follow: no public data
Portfolio highlights
- HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
- Sellmyartworks — EzelDotz - Buy and Sell Contemporary Art Online | Art Marketplace. Curated collection of Sculptures, Limited Editions and Originals.
- Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality
By Your Side from Day One
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 624
- Round size: Seed $658k–$8M; Pre-Seed $587k–$3.5M; Series A $5M–$30M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely actively investing — fresh fund, raised $220M in 2026
Portfolio highlights
- Rayon — Built for Speed. Designed for Teams.
- Metaview — Metaview uplevels the most outcome-defining part of your recruitment process: your interviews.
- Solvera AI — Solvera is an AI-native engineering firm on a mission to unleash the potential of every building engineer with AI. It develops advanced proprietary AI systems to help design better buildings, significantly faster, establishing a brand-new standard for MEP engineering.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 278
- Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$60M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $85M in 2023
Portfolio highlights
- iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
- Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Meltwind Advisory.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 32
- Round size: Seed $1.2M–$16M; Pre-Seed $996k–$2.5M; Series A $2.9M–$94M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- IMU Biosciences — IMU is a discovery engine mapping the immune system to advance precision medicine.
- Qureight — Pioneering data curation to solve complex diseases
- Syndex Bio — Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 210
- Round size: Seed $233k–$4M; Pre-Seed $197k–$1.3M; Venture - Series Unknown $477k–$5.7M
- Lead/follow: 51% lead, 49% follow
Portfolio highlights
- Go Swag — Branded swag people want to keep, designed, sourced, stored and delivered by one team to 180+ countries. Managed programmes, Studio projects and Select.
- Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
- Farmdrive — Farmdrive helps supply chain partners create transparent, effective, and resilient operations from farm to shelf by streamlining data collection and simplifying farm management.
24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growth agenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 108
- Round size: Seed $736k–$3.7M; Series A $1.8M–$16M; Venture - Series Unknown $107k–$4.3M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- WATR — WATR is the integrated system for real-time water or soil quality monitoring. Our products are robust, reliable, accurate, easy to use and benchmarked for accuracy.
- pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Previsico — Live, property-level surface water and flash flood forecasting. Previsico gives insurers, brokers and large organisations 48-hour advance flood warnings - specific enough to act on, proven to mitigate losses.
Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 20
- Round size: Seed $1.4M–$9.6M; Pre-Seed $1.1M–$2.5M; Series A $3.5M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Mesh Bio — We enable digital transformation of care delivery through clinical workflow automation and predictive analytics, built on gold standard clinical guidelines and best practices.
- BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
- MultiOmic Health — AI-Enabled Precision Medicine for Metabolic Syndrome
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 222
- Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $19M–$111M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fresh fund, raised $606M in 2026
Portfolio highlights
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
- Solstice Oncology — Solstice Oncology is a clinical stage immuno-oncology company developing a therapeutic that meets cancer at its most vulnerable moment, before surgery, to drive deep pathological response and return patients to lasting health. The company's lead program is targeting colon cancer.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Biotechnology Investor funding in United Kingdom at a glance
Stats across 3k deals from 2.2k investors.
Access all 2246 investors in United Kingdom Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 2246 investors investing in United Kingdom Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!